Don't panic: severe soft tissue infections are extremely rare. But if you do develop one, you and your doctor need to act quickly. An EU-funded project is working on a powerful diagnostic tool that can help to spot these potentially fatal illnesses early. The team is also analysing patient records and samples from several countries to identify the best treatments.
New vaccines could be developed more quickly and be better targeted to specific age groups, thanks to EU-funded research. A five-year project has been studying novel immunisation technologies, boosting international efforts in vaccine research.
Arthritis is very common - so common, indeed, that aching joints may seem inevitable as we age. They are not, of course, and even if the condition does set in, treatment can often slow it down. MRI combined with nanoparticles developed by an EU-funded project could soon help to spot main forms of the disease much earlier.
Could Europe's economy reduce its CO2 emissions by 95% by 2050? An EU-funded project has predicted how an integrated smart grid could evolve by 2050, supporting greater use of green power and a secure, reliable energy supply.
Unfortunately the threat of a terrorist attack on an aeroplane is today a real threat to airline security. The EU-funded FLY-BAG2 project has developed a technology that enables aeroplanes to survive a Lockerbie-type explosion scenario. The bomb-resistant bags are ready to be manufactured and installed.
A portable device to detect potential signs of cancer in a patient's urine is under development within the EU-funded research project GLAM. The project aims to speed up cancer diagnosis and monitoring, while making the process both less intrusive and less unpleasant.
How close are we to developing a successful and comprehensive vaccine for cancer? ERC grantee Prof. Yvette van Kooyk thinks that a combination of glycobiology and immunology will lead us closer than ever before. Thanks to her ground-breaking multidisciplinary team and her new approach based on sugar receptors, she has developed a nanovaccine that promises to represent the future for cancer treatment.
New technologies claiming to protect pedestrians and cyclists in the event of a collision are being developed all the time. They could reduce pedestrian fatalities by 15-20%. But how do we know which systems are effective? How can we compare them? An EU-funded project drew up harmonised test and assessment procedures for pedestrian safety systems.
Despite enormous progress in the prevention and treatment of HIV/AIDS, the global response cannot keep pace: 35 million people are living with HIV worldwide with around 6,000 new infections each day. Numerous HIV prevention strategies, though proven successful, are difficult to sustain long-term. A vaccine still represents the most effective tool in the combat against HIV from a public health perspective.